These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 382519)

  • 1. The immunogenetic influence of non-MSH systems on rat renal allograft survival.
    Bishop CE; Paris AM; Festenstein H; Günther E
    Transplant Proc; 1979 Jun; 11(2):1351-2. PubMed ID: 382519
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenetic studies in semi-inbred pigs.
    Pazdera J; Hruban V; Hradecký J; Fortýn K; Stanĕk R; Pospísil M; Jílek M
    Folia Biol (Praha); 1981; 27(2):96-106. PubMed ID: 7016604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney transplantation across multiple non-MHC differences in the Norway rat.
    Pávková L; Stejskal J; Kren V
    Folia Biol (Praha); 1978; 24(6):359-60. PubMed ID: 365610
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of the RT1.C region in rat allotransplantation.
    Klempnauer J; Steiniger B; Marquarding E; Vogt P; Lipecz A; Wonigeit K; Günther E
    Transplant Proc; 1987 Feb; 19(1 Pt 1):713-5. PubMed ID: 3274851
    [No Abstract]   [Full Text] [Related]  

  • 5. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
    Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW
    Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of the rat to the immunobiology of tissue transplantation.
    Silvers WK; Billingham RE
    Transplant Proc; 1970 Mar; 2(1):152-61. PubMed ID: 4398945
    [No Abstract]   [Full Text] [Related]  

  • 8. Delayed elimination of donor red blood cells is associated with host major histocompatibility complex and donor-specific blood transfusion enhancement of rat renal allograft survival.
    Wasowska B; Baldwin WM; Sanfilippo F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):241-2. PubMed ID: 8438285
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-major histocompatibility system immunogenetic influences in rat renal allograft survival.
    Paris AM; Bishop C; Festenstein H; Gunther E
    Transplantation; 1978 May; 25(5):252-4. PubMed ID: 349800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development and characteristics of new MHC congenic strains BN. 1B, BP. 1N and questions concerning the genetic background.
    Kren V; Bílá V; Krenová D; Jirásek A
    Folia Biol (Praha); 1978; 24(6):357-8. PubMed ID: 365609
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of combined therapy with prostaglandin E1 and cyclosporine A on rat heart allograft survival.
    Ozawa T; Kamada N; Ashizawa T; Aoki T; Koyanagi Y; Kimura K
    Transplant Proc; 1991 Aug; 23(4):2213-4. PubMed ID: 1871850
    [No Abstract]   [Full Text] [Related]  

  • 12. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of reexposure to mismatched major histocompatibility complex antigens on renal retransplant allograft survival.
    Farney AC; Noreen HJ; Sutherland DE; Reinsmoen N; Segall M; Gillingham K; Schmidt WJ; Matas AJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):213-4. PubMed ID: 8438275
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolonged heart allograft survival following postoperative blood transfusion.
    Marushack MM; Snider GR; Muka-Ives M; Nelson EW; Maxwell JG; Shelby J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1420-1. PubMed ID: 3274343
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of haplotypes of the major histocompatibility complex of the rat.
    Stark O; Kunz HW; Gill TJ
    Folia Biol (Praha); 1978; 24(6):403-5. PubMed ID: 365614
    [No Abstract]   [Full Text] [Related]  

  • 16. Skin graft survival across RT1 and non-RT1 barriers in rats.
    Jones JM
    Transplantation; 1981 Apr; 31(4):311-2. PubMed ID: 7013177
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of sphingosine-1-phosphate 1 receptor agonist, KRP-203, in combination with a subtherapeutic dose of cyclosporine A for rat renal transplantation.
    Fujishiro J; Kudou S; Iwai S; Takahashi M; Hakamata Y; Kinoshita M; Iwanami S; Izawa S; Yasue T; Hashizume K; Murakami T; Kobayashi E
    Transplantation; 2006 Sep; 82(6):804-12. PubMed ID: 17006328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts.
    Takahashi M; Shimizu H; Murakami T; Enosawa S; Suzuki C; Takeno Y; Hakamata Y; Kudou S; Izawa S; Yasue T; Kobayashi E
    Transplant Proc; 2005; 37(1):143-5. PubMed ID: 15808575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histocompatibility requirements of heart and skin grafts in rats.
    Barker CF; Billingham RE
    Transplant Proc; 1971 Mar; 3(1):172-5. PubMed ID: 4937886
    [No Abstract]   [Full Text] [Related]  

  • 20. Kidney transplantation genetics and enhancement in rats.
    Mullen Y; Hildemann WH
    Transplant Proc; 1971 Mar; 3(1):669-72. PubMed ID: 4106333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.